惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

S
SegmentFault 最新的问题
G
Google Developers Blog
Stack Overflow Blog
Stack Overflow Blog
WordPress大学
WordPress大学
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
罗磊的独立博客
月光博客
月光博客
IT之家
IT之家
爱范儿
爱范儿
Google DeepMind News
Google DeepMind News
小众软件
小众软件
C
Check Point Blog
B
Blog RSS Feed
H
Help Net Security
博客园 - 司徒正美
L
LangChain Blog
MongoDB | Blog
MongoDB | Blog
B
Blog
The Cloudflare Blog
Apple Machine Learning Research
Apple Machine Learning Research
Microsoft Security Blog
Microsoft Security Blog
M
MIT News - Artificial intelligence
N
Netflix TechBlog - Medium
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earni...
2026-05-06 · via All Articles on Seeking Alpha

Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call May 5, 2026 4:30 PM EDT

Company Participants

Karina Calzadilla - Vice President of Investor Relations
Chad Robins - Co-Founder, CEO & Chairman
Kyle Piskel - VP, CFO & Principal Accounting Officer
Susan Bobulsky - Chief Commercial Officer of MRD

Conference Call Participants

Andrew Brackmann - William Blair & Company L.L.C., Research Division
David Westenberg - Piper Sandler & Co., Research Division
Mark Massaro - BTIG, LLC, Research Division
Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division
Sebastian Sandler - JPMorgan Chase & Co, Research Division
Daniel Brennan - TD Cowen, Research Division
John Wilkin

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies First Quarter Financial Results. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Karina Calzadilla, Head of Investor Relations. Please go ahead.

Karina Calzadilla
Vice President of Investor Relations

Thank you, Anton, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies First Quarter 2026 Earnings Conference Call. Earlier today, we issued a press release reporting Adaptive financial results for the first quarter of '26. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to the Investors section in our corporate website.

During the call, management will make projections and other forward-looking statements within the meaning of federal securities laws regarding future events and the future financial performance of the company. These statements reflect management's current perspective of the business as of today. Actual results may differ materially from today's forward-looking statements, depending on a number of factors, which are set forth in our public filings with the SEC and listed in this presentation.